Wilmington, North Carolina Clinical Trials

A listing of Wilmington, North Carolina clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 110 clinical trials
featured
Moderate-to-Severe Endometriosis Pain

A research study is evaluating an FDA-approved medication for pain associated with endometriosis combined with an oral contraceptive.  

  • 169 views
  • 23 Nov, 2020
  • 1 location
featured
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients with Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients with Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

Research Center
 (0.0 away) Contact site
  • 1940 views
  • 25 Mar, 2021
  • +106 other locations
featured
We are currently recruiting patients with Palmoplantar Pustulosis (PPP). This study investigates the Efficacy and safety of ANB019.

The study drug consists of a sub-cutaneous investigational treatment or a placebo, that will be administered on Day 1, followed by 3 doses of the study treatment on Days 29, Day 57 and Day 85. Several blood samples will be collected throughout the study. Your participation in the biopsy portion …

skin disease
skin disorder
psoriasis
WDC Cosmetic and Research PLLC
 (3.3 away) Contact site
  • 28 views
  • 22 Dec, 2020
  • +23 other locations
featured
Intranasal Migraine Treatment Trial

Double-Blind, Randomized, Placebo Controlled, Safety and Efficacy Trial of BHV-3500 (zavegepant) Intranasal (IN) for the Acute Treatment of Migraine

Wilmington Health, PLLC
 (2.9 away) Contact site
  • 0 views
  • 10 Jun, 2021
  • +81 other locations
Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Carcinoma

This is a randomized (1:1), double-blind, placebo-controlled, Phase 3 study designed to compare the efficacy and safety of tislelizumab or placebo plus chemotherapy as first-line (1L) therapy for locally advanced unresectable or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma.

New Mexico Cancer Care Alliance/University of New Mexico Comprehensive Cancer Center
 (131.9 away) Contact site
  • 38 views
  • 25 Jan, 2021
  • +193 other locations
IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study

IBP-9414 will be evaluated in preterm infants with a birth weight of 500-1500g, compared to placebo with regards to efficacy and safety in the prevention of necrotizing enterocolitis.

New Hanvover Regional Medical Center
 (5.8 away) Contact site
  • 1 views
  • 08 Apr, 2021
  • +72 other locations
Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

The main purpose of the study is to assess the efficacy and safety of nemolizumab after a 16-week treatment period in adult and adolescent subjects with moderate-to-severe atopic dermatitis (AD) not adequately controlled with topical treatments.

Galderma Investigational Site
 (5.2 away) Contact site
  • 95 views
  • 16 Jul, 2021
  • +458 other locations
Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis

Long-Term Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-Severe Atopic Dermatitis Description

Galderma Investigational Site
 (5.2 away) Contact site
  • 21 views
  • 16 Jul, 2021
  • +470 other locations
PRISM Study-Pruritus Relief Through Itch Scratch Modulation

To investigate the anti-pruritic efficacy and safety of Nalbuphine ER (NAL ER) tablets in Prurigo Nodularis. Subjects will be randomized to NAL ER (or matching placebo) with the primary endpoint evaluation at Week 14. During the open label extension, subjects who received NAL ER will continue on NAL ER and …

nalbuphine
Study Site 101
 (9.6 away) Contact site
  • 661 views
  • 31 Jul, 2021
  • +85 other locations
A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

The purpose of the study is to evaluate the efficacy, safety, and immunogenicity of ABP 654 compared with ustekinumab in participants with moderate to severe plaque psoriasis.

Wilmington Dermatology Center
 (6.9 away) Contact site
  • 0 views
  • 26 Jun, 2021
  • +157 other locations